DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zaditor (Ketotifen Fumarate Ophthalmic) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

ZADITOR SUMMARY

Zaditor

ZADITOR™ is a sterile ophthalmic solution containing ketotifen for topical administration to the eyes.

ZADITOR™ (ketotifen fumarate ophthalmic solution) is indicated for the temporary prevention of itching of the eye due to allergic conjunctivitis.


See all Zaditor indications & dosage >>

ZADITOR NEWS HIGHLIGHTS

Published Studies Related to Zaditor (Ketotifen Ophthalmic)

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. [2008.07.08]

Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. [2005.09]

Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population. [2004.12]

Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis. [2003.12]

Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis. [2003.10]

more >>

Clinical Trials Related to Zaditor (Ketotifen Ophthalmic)

Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis [Completed]

Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis [Completed]

Evaluation of Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge(CAC) Model of Acute Allergic Conjunctivitis. [Not yet recruiting]

Evaluation of a Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis. [Recruiting]

Montelukast Post-Marketing Comparative Study With Ketotifen [Completed]

more >>

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008